Overview
Compare with SenesTech, Inc., Cibus, Inc. or Evogene Ltd, or pick any stock.
- TickerBNET on OTC1
- IndustryAgricultural Chemicals1
- HeadquartersOld Bethpage, New York1
- Incorporated inCO3
- Business addressPo Box 323, Old Bethpage, Ny 118043
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation
See how the biggest companies compare on our leaderboards
Bion has faced, the Company is now ready for successful commercial launch, having accomplished the following:4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| General and administrative (including stock-based compensation) | $1.3M | $2.1M | |
| Depreciation | $695 | ||
| Research and development (including stock-based compensation) | $27.5K | $21.7K | |
| Total operating expenses | $1.3M | $2.2M | |
| Loss from operations | -$1.3M | -$2.2M | |
| Interest income | -$89 | -$62 | |
| Interest expense | $632.4K | $310.7K | |
| Gain on debt forgiveness | -$98.2K | ||
| Other income | -$2.5K | ||
| Total other expense | $629.8K | $212.4K | |
| Net (loss) | -$2.0M | -$2.4M | $11.7M |
| Net (loss) applicable to Bion's common stockholders | -$2.0M | -$2.4M | |
| Net (loss) applicable to Bion's common stockholders per basic common share | -$0.03 | -$0.04 | |
| Net (loss) applicable to Bion's common stockholders per diluted common share | -$0.03 | -$0.04 | |
| Weighted-average number of common shares outstanding, Basic | 57.1M shares | 56.7M shares | |
| Weighted-average number of common shares outstanding Diluted | 57.1M shares | 56.7M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash | $3.7K | $4.4K | $52.2K |
| Prepaid expenses | $17.9K | $15.6K | |
| Deposits and other assets | $14.0K | $9.2K | |
| Total current assets | $35.6K | $29.2K | |
| Total assets | $35.6K | $29.2K | |
| Accounts payable and accrued expenses | $2.9M | $2.8M | |
| Deferred compensation (Note 4) | $1.4M | $1.2M | |
| Convertible notes payable (Note 5) | $1.4M | $2.3M | |
| Convertible bridge note payable (Note 5) | $491.3K | $455.0K | |
| Note payable - related party (Note 5) | $475.8K | $423.1K | |
| Demand note payable - related party (Note 5) | $21.9K | ||
| Total current liabilities | $6.7M | $7.1M | |
| Convertible notes payable (Note 5) | $506.2K | ||
| Total liabilities | $7.2M | $7.1M | |
| Shares to be issued (Note 8) | $1.5M | ||
| Additional paid-in capital | $134.5M | $134.7M | |
| Subscription receivable - affiliates (Note 7) | -$504.6K | ||
| Accumulated deficit | -$143.3M | -$141.3M | |
| Total Bion's stockholders equity (deficit) | -$7.2M | -$7.1M | |
| Noncontrolling interest | $37.6K | $37.6K | |
| Total equity (deficit) | -$7.2M | -$7.1M | -$5.8M |
| Total liabilities and Equity (deficit) | $35.6K | $29.2K | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 250.0M shares | 250.0M shares | |
| Common stock, shares issued | 58.1M shares | 57.4M shares | |
| Common stock, shares outstanding | 57.4M shares | 56.7M shares |
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash | $3.7K | $4.4K | $52.2K |
| Prepaid expenses | $17.9K | $15.6K | |
| Deposits and other assets | $14.0K | $9.2K | |
| Total current assets | $35.6K | $29.2K | |
| Total assets | $35.6K | $29.2K | |
| Accounts payable and accrued expenses | $2.9M | $2.8M | |
| Deferred compensation (Note 4) | $1.4M | $1.2M | |
| Convertible notes payable (Note 5) | $1.4M | $2.3M | |
| Convertible bridge note payable (Note 5) | $491.3K | $455.0K | |
| Note payable - related party (Note 5) | $475.8K | $423.1K | |
| Demand note payable - related party (Note 5) | $21.9K | ||
| Total current liabilities | $6.7M | $7.1M | |
| Convertible notes payable (Note 5) | $506.2K | ||
| Total liabilities | $7.2M | $7.1M | |
| Shares to be issued (Note 8) | $1.5M | ||
| Additional paid-in capital | $134.5M | $134.7M | |
| Subscription receivable - affiliates (Note 7) | -$504.6K | ||
| Accumulated deficit | -$143.3M | -$141.3M | |
| Total Bion's stockholders equity (deficit) | -$7.2M | -$7.1M | |
| Noncontrolling interest | $37.6K | $37.6K | |
| Total equity (deficit) | -$7.2M | -$7.1M | -$5.8M |
| Total liabilities and Equity (deficit) | $35.6K | $29.2K | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 250.0M shares | 250.0M shares | |
| Common stock, shares issued | 58.1M shares | 57.4M shares | |
| Common stock, shares outstanding | 57.4M shares | 56.7M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Net (loss) | -$2.0M | -$2.4M | $11.7M |
| Depreciation expense | $0 | $695 | |
| Accrued interest on loans payable, deferred compensation and other | $632.4K | $310.7K | |
| Stock-based compensation | $124.7K | $843.5K | |
| Stock-based compensation for services | $34.5K | ||
| Forgiveness of debt | -$98.2K | ||
| (Increase) decrease in prepaid expenses | -$7.1K | -$2.1K | |
| Increase in accounts payable and accrued expenses | $67.8K | $155.1K | |
| (Increase) in operating lease assets and liabilities | $191 | ||
| Increase in deferred compensation | $334.0K | $267.2K | |
| Net cash used in operating activities | -$806.3K | -$868.2K | |
| Proceeds from convertible notes payable | $788.8K | $426.0K | |
| Proceeds from demand note | $24.7K | ||
| Payments on demand note | -$5.0K | ||
| Proceeds from note payable loan, related party | $16.0K | $399.8K | |
| Commissions on proceeds from convertible notes payable | -$18.9K | -$5.3K | |
| Net cash provided by financing activities | $805.6K | $820.5K | |
| Net decrease in cash | -$771 | -$47.8K | |
| Settlement agreements - cancellation of convertible obligations, deferred compensation and subscription receivables for shares to be issued | $723.6K | ||
| Adjustment for offsetting subscription receivable with deferred compensation | $61.0K |
No quarter-by-quarter statement was filed.
Compare BION ENVIRONMENTAL TECHNOLOGIES INC with another company
What it owns
What BION ENVIRONMENTAL TECHNOLOGIES INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $12.6K5 Jun 30, 2025 | $12.6K5 Jun 30, 2024 | 0% |
| Accumulated depreciation | $12.6K2 Jun 30, 2026 | $12.6K2 Jun 30, 2025 | 0% |
Properties, in its own words
The Company maintains its corporate offices at 9 East Park Court, Old Bethpage, New York 11804, the home of its office manager/bookkeeper, and its main corporate telephone number is (406) 839-0816.
We are the sole owner of six United States patents. Additionally, Bion has two United States patent applications pending and has three international patent applications currently pending. (See Item 1, “Patents” above).
Item 2 of the 10-K filed Sep 29, 2026.4
Leadership
Who has led BION ENVIRONMENTAL TECHNOLOGIES INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief operating officer
- Chief executive officerStephen Craig Scott Dec 16, 2024 to now16
- Chief executive officerDominic Bassani Jun 9, 2011 to Feb 27, 202317
- ChairSalvatore J. Zizza Jan 12, 2007 to Jan 9, 200918
- Chief operating officerGregory W. Schoener Oct 28, 2024 to now19
- Chief operating officerDominic Bassani May 5, 2022 to May 5, 202220
- Chief operating officerGeorge Bloom Jan 12, 2007 to Jun 9, 200821
- Chief operating officerJeremy Rowland Jan 12, 2007 to Jun 6, 200822
Board members and other officers (13)
- Vice chairEdward T. Schafer Jan 4, 2011 to Feb 27, 202323
- Senior Technology DirectorJere Northrop Jan 12, 2007 to Jul 2, 200924
- SecretaryJon Northrop Jan 12, 2007 to Feb 23, 202325
- Board memberStephen J. Posner Jun 12, 2025 to now26
- Board memberStephen Craig Scott Jun 26, 2024 to now27
- Board memberGregory W. Schoener Jul 1, 2024 to now28
- Board memberRobert D. Weerts Jul 15, 2024 to now29
- Board memberTurk Courtney Stovall Jul 19, 2024 to now30
- Board memberSalvatore J. Zizza Mar 16, 2023 to Mar 16, 202331
- Board memberWilliam F. Rupp Mar 20, 2023 to Mar 20, 202332
- Board memberEdward T. Schafer Jan 4, 2011 to Feb 27, 202323
- Board memberJere Northrop Jan 12, 2007 to Jul 2, 200924
- Board memberJon Northrop Jan 12, 2007 to Feb 23, 202325
Named in SEC Form D filings
People the company listed in its private-offering notices.
Timeline
- Oct 6, 20268-K Other events35
- Aug 27, 20268-K Other events36
- Aug 13, 20268-K Executive or director change; Bylaws or fiscal year changed37
- Jul 14, 20268-K Entered a material agreement; Regulation FD disclosure38
- Jun 11, 20268-K Other events39
- Feb 12, 20268-K Regulation FD disclosure40
- Jan 27, 20268-K Other events41
- Jan 8, 20268-K Entered a material agreement42
- Jan 7, 20268-K Entered a material agreement43
- Dec 9, 20258-K Regulation FD disclosure; Other events44
- Oct 8, 20258-K Entered a material agreement45
- Sep 30, 20258-K Executive or director change46
- Dec 16, 2024New chief executive Stephen Craig Scott becomes CEO16
- Jun 9, 2011New chief executive Dominic Bassani becomes CEO17
Filings
173 filings to the SEC since October 2021: 6 annual reports, 16 quarterly reports, 60 major events, 71 insider forms, 14 private raises, 6 other. The latest 20:
- Oct 6, 20268-K EDGAR
- Sep 29, 202610-K ANNUAL REPORT EDGAR
- Sep 28, 2026NT 10-K EDGAR
- Aug 27, 20268-K EDGAR
- Aug 13, 20268-K EDGAR
- Jul 14, 20268-K EDGAR
- Jun 11, 20268-K EDGAR
- May 15, 202610-Q QUARTERLY REPORT EDGAR
- Feb 17, 202610-Q EDGAR
- Feb 12, 20268-K EDGAR
- Feb 2, 2026D EDGAR
- Jan 27, 20268-K EDGAR
- Jan 8, 20268-K EDGAR
- Jan 7, 20268-K EDGAR
- Dec 9, 20258-K EDGAR
- Nov 14, 202510-Q EDGAR
- Oct 8, 20258-K EDGAR
- Sep 30, 20258-K EDGAR
- Sep 29, 202510-K EDGAR
- Sep 18, 20258-K EDGAR
The 173 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
111 open-market trades by officers, directors and large owners since October 2021: 26 buys and 85 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 28, 2023 | Orphanos Anthony10% owner | Sale | 11,500 | $1.14 | $13.1K | Form 4 |
| Jul 27, 2023 | Orphanos Anthony10% owner | Sale | 3,500 | $1.15 | $4.0K | Form 4 |
| Jul 13, 2023 | Orphanos Anthony10% owner | Sale | 12,291 | $1.10 | $13.5K | Form 4 |
| Jul 6, 2023 | Orphanos Anthony10% owner | Sale | 3,000 | $1.17 | $3.5K | Form 4 |
| Jul 5, 2023 | Orphanos Anthony10% owner | Sale | 3,709 | $1.20 | $4.5K | Form 4 |
| Jun 30, 2023 | Orphanos Anthony10% owner | Sale | 6,000 | $1.24 | $7.4K | Form 4 |
| Jun 14, 2023 | Orphanos Anthony10% owner | Sale | 13,500 | $1.21 | $16.3K | Form 4 |
| Jun 9, 2023 | Orphanos Anthony10% owner | Sale | 8,000 | $1.25 | $10.0K | Form 4 |
| Jun 7, 2023 | Orphanos Anthony10% owner | Sale | 3,500 | $1.28 | $4.5K | Form 4 |
| Jun 1, 2023 | Orphanos Anthony10% owner | Sale | 8,100 | $1.28 | $10.4K | Form 4 |
| May 31, 2023 | Orphanos Anthony10% owner | Sale | 3,500 | $1.25 | $4.4K | Form 4 |
| May 30, 2023 | Orphanos Anthony10% owner | Sale | 7,000 | $1.27 | $8.9K | Form 4 |
| May 25, 2023 | Orphanos Anthony10% owner | Sale | 11,500 | $1.30 | $14.9K | Form 4 |
| May 17, 2023 | Orphanos Anthony10% owner | Sale | 2,149 | $1.38 | $3.0K | Form 4 |
| May 16, 2023 | Orphanos Anthony10% owner | Sale | 14,500 | $1.30 | $18.9K | Form 4 |
| May 12, 2023 | Orphanos Anthony10% owner | Sale | 3,851 | $1.41 | $5.4K | Form 4 |
| May 11, 2023 | Orphanos Anthony10% owner | Sale | 1,003 | $1.40 | $1.4K | Form 4 |
| May 10, 2023 | Orphanos Anthony10% owner | Sale | 10,000 | $1.40 | $14.0K | Form 4 |
| May 9, 2023 | Orphanos Anthony10% owner | Sale | 5,000 | $1.40 | $7.0K | Form 4 |
| May 3, 2023 | Orphanos Anthony10% owner | Sale | 1,500 | $1.50 | $2.2K | Form 4 |
All 111 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Money raised
Private offerings the company reported to the SEC on Form D.
- Jan 27, 2026Raised $25,000 in a private offering of securities Form D: $3 million offered in all Form D
- Aug 13, 2025Raised $50,000 in a private offering of securities Form D: $3 million offered in all Form D
- Jun 6, 2025Raised $50,000 in a private offering of debt Form D: $1.5 million offered in all Form D
- Feb 18, 2025Raised $25,000 in a private offering of debt Form D: $1.5 million offered in all Form D
- Dec 16, 2024Raised $25,000 in a private offering of debt Form D: $1.5 million offered in all Form D
- May 31, 2024Raised $100,000 in a private offering of debt Form D: $4 million offered in all Form D
- Jan 30, 2024Raised $10,000 in a private offering of equity Form D: $6 million offered in all Form D
- Dec 28, 2023Raised $300,000 in a private offering of equity Form D: 1 investor so far Form D
- Dec 22, 2023Raised $75,000 in a private offering of equity Form D: $6 million offered in all Form D
- Oct 6, 2023Raised $1.5 million in a private offering of debt Form D: 1 investor so far Form D
- Mar 8, 2023Raised $320,000 in a private offering of equity Form D: $10 million offered in all Form D
- Dec 30, 2022Raised $2 million in a private offering of equity Form D: 1 investor so far Form D
- Jul 6, 2022Raised $300,000 in a private offering of equity Form D: $320,000 offered in all Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Howard Capital Management Group, LLC | 55,157 | $9.0K | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How BION ENVIRONMENTAL TECHNOLOGIES INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBION ENVIRONMENTAL TECHNOLOGIES INC1
- CIK0000875729
- Employer ID (EIN)84-11766724
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inColorado4
- Fiscal year endsJune 301
- Industry code (SIC)2870 Agricultural Chemicals1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business addressPo Box 323, Old Bethpage, NY 118041
- Phone406-839-08161
- Shares outstanding57,412,311 shares as of Aug 1, 20264
- Public float$8.8M as of Jun 30, 20264
- AuditorHaynie, Salt Lake City, Utah PCAOB ID 457; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceMay 15, 19961
- Filings844 in all: 4 (274), 8-K (230), D (57), 10-Q (56), 10QSB (26), 3 (26), 10-K (20), S-8 (16)1
All 44 form types
D/A (11), 4/A (9), SC 13G (9), UPLOAD (9), 10KSB (8), 10QSB/A (8), 8-K/A (7), CORRESP (7), 10KSB/A (6), SC 13D (5), SC 13D/A (5), 10SB12G/A (4), NT 10-K (4), S-2/A (4), SC 13G/A (4), 10-K/A (3), 424B3 (3), DEF 14A (3), NT 10-Q (3), PRE 14A (3), S-3/A (3), 10-Q/A (2), DEFA14A (2), REGDEX (2), RW WD (2), S-2 (2), S-3 (2), 10SB12G (1), 15-12G (1), 3/A (1), 5 (1), 8-A12B (1), CERTPBS (1), CT ORDER (1), NO ACT (1), RW (1)
- Latest filingsAnnual report (10-K) Sep 29, 2026
Quarterly report (10-Q) May 15, 2026
Proxy statement (DEF 14A) Feb 7, 2022
Latest 8-K (8-K) Oct 6, 2026
Risk factors and legal proceedings
The risks BION ENVIRONMENTAL TECHNOLOGIES INC names in Item 1A of its 10-K filed Sep 29, 2026: 1 risk under these headings, as written.4
- Risks Relating to our Common Stock
Legal proceedings
1) Convertible Bridge Loan/Default
On September 28, 2023, the Company entered into an agreement for a $1,500,000 bridge loan with SEB LLC, a non-affiliated party (the "Lender"), and executed a convertible promissory note (the "Note") and a binding subscription agreement (together, the "Bridge Loan Agreements"). The Bridge Loan Agreements required the Lender to loan the Company $1,500,000 in six monthly tranches of $250,000 beginning in October 2023. All amounts advanced, together with interest accrued at 9% per annum, were due and payable on October 1, 2024, if not previously converted. The Note is convertible at the sole election of the Lender at $1.00 per unit, each unit consisting of one share of the Company's common stock and a warrant to purchase one-half share. The Company received the initial $250,000 tranche on October 5, 2023. In early November 2023, the Lender informed the Company verbally that it did not intend to fund the remaining tranches, and no further tranches were received.
On May 10, 2024, the Company received an additional $150,000 from affiliates of the Lender, in connection with discussions regarding a potential larger investment by affiliates and/or associates of the Lender. The larger transaction was never completed. The Company has included the $150,000 in the convertible bridge note balance and accrues interest on it at 9% per annum, consistent with the terms of the Note. The funds were used primarily to restart operations at the Initial Project.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARSalvatore J. Zizza, Chair
- 19
- 20
- 21
- 22
- 23SEC EDGAREdward T. Schafer, Vice chair
- 24
- 25SEC EDGARJon Northrop, Secretary
- 26SEC EDGARStephen J. Posner, Board member
- 27SEC EDGARStephen Craig Scott, Board member
- 28SEC EDGARGregory W. Schoener, Board member
- 29SEC EDGARRobert D. Weerts, Board member
- 30SEC EDGARTurk Courtney Stovall, Board member
- 31SEC EDGARSalvatore J. Zizza, Board member
- 32SEC EDGARWilliam F. Rupp, Board member
- 33
- 34
- 35SEC EDGAROther events
- 36SEC EDGAROther events
- 37
- 38
- 39SEC EDGAROther events
- 40SEC EDGARRegulation FD disclosure
- 41SEC EDGAROther events
- 42SEC EDGAREntered a material agreement
- 43SEC EDGAREntered a material agreement
- 44
- 45SEC EDGAREntered a material agreement
- 46SEC EDGARExecutive or director change